Cite
HARVARD Citation
El‐Naggar, A. et al. (2019). Class I HDAC inhibitors enhance YB‐1 acetylation and oxidative stress to block sarcoma metastasis. EMBO reports. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
El‐Naggar, A. et al. (2019). Class I HDAC inhibitors enhance YB‐1 acetylation and oxidative stress to block sarcoma metastasis. EMBO reports. p. n/a. [Online].